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Summary
Activity-prompted dendritic remodeling [1, 2] leads to
calcium-influx-dependent activation of signaling path-
ways within minutes and gene transcription within
hours [3–6]. However, dendrite growth continues for
days [2, 3, 7–9] and requires extension and stabiliza-
tion of the cytoskeleton in nascent processes [8]. In
addition to binding microtubules [10], microtubule-
associated proteins (MAPs) associate with the actin
cytoskeleton [11–13], anchor ion channels [14–19]
and signaling complexes [17, 20], and modulate syn-
aptic growth [21]. MAP2 is predominantly dendritic
[22–24]. MAP1B is at postsynaptic densities (PSD)
[25] and modulates ion channel activity [26], in addi-
tion to affecting axon growth [27, 28]. Less is known
about MAP1A [10, 29–32], but it is also enriched in
dendrites [29, 32] at input locations [33], including
PSDs where MAP1A associates with channel com-
plexes [19, 34] and the calcium sensor caldendrin
[35]. MAP1A rescued hearing loss in tubby mice [36].
Here we show that MAP1A becomes enriched in den-
drites concurrently with dendritic branching and syn-
apse formation in the developing brain; that synaptic
activity is required for establishing mature MAP1A ex-
pression levels; and that MAP1A expression is re-
quired for activity-dependent growth, branching, and
stabilization of the dendritic arbor.
Results and Discussion
In the adult brain, MAP1A is enriched in dendrites, in-
cluding dendrites of Purkinje cells and pyramidal neu-
rons in the hippocampus and cortex (Figure 1; Figure
S1 in the Supplemental Data available with this article
online). Dendrites containing both MAP1A and MAP2
are common, but overall patterns are quite different.
Typically, MAP2 is more generally distributed than*Correspondence: stbrady@uic.eduMAP1A (Figure 1A; Figure S1). No MAP1A was detected
in mature, myelinated axons beyond the initial segment
in major tracts, such as the corpus callosum and cere-
bellar white matter (Figures 1A–1B). In contrast, promi-
nent staining was seen in white matter of younger
brains, and some of this staining was clearly localized
in cell bodies and processes within the white matter
(Figure S2). Restricted dendritic localization of MAP1A
was reported previously [33, 37]. Interestingly, a spe-
cific form of MAP1A was enriched in layer IV of the bar-
rel cortex at the terminal field of thalamo-cortical pro-
jections of whisker sensory input [33]. Although we do
not know whether the antibodies we used are directed
to specific MAP1A forms, the MAP1A recognized is low
in mature axons and enriched in specific dendritic do-
mains, and expression levels change with neuronal ac-
tivity (see below).
MAP1A levels rise during the second postnatal week
in the brain (Figure S3), when afferent inputs are estab-
lished, dendrites elongate and branch, and synapses
form. This increase is concurrent with a decline in the
structurally related MAP1B, found in growing axons,
and is delayed relative to the rise in MAP2. Among sev-
eral markers for neuronal maturation, the pattern of the
rise in MAP1A was most similar to that of synaptophy-
sin (Syp), a synaptic marker [38]. MAP1A was first de-
tected in Purkinje soma at P5 (Figure S3B), whereas
MAP2 and calbindin were seen earlier (at P1, not shown).
Also, in Purkinje cell cultures MAP1A expression lagged
behind that of calbindin (Figure 1D). At each age,
MAP1A distribution was more restricted than that of
calbindin and MAP2 and was not detected in axons be-
yond the initial segment (Figures 1C–1D; Figure S3). Be-
tween P5 and P16, when granule-cell parallel fibers es-
tablish synapses on Purkinje cells, MAP1A staining
increased in Purkinje cell dendrites. These results sug-
gest a role for MAP1A in a later stage of dendritic matu-
ration rather than in initial outgrowth.
In cultured hippocampal neurons, MAP1A levels rose
most dramatically between 4 and 7 days in vitro (DIV)
(Figure 1E), a time of increased dendrite growth and
branching (Figures 1F, 2, and 3; Table S1). This time
course of dendritic development in our cultures matches
results of previous reports [39] and parallels the time of
synapse formation in these cultures. Synaptic develop-
ment in cultures of embryonic hippocampal neurons
has been described in detail. The number of synapses
(based on synapsin I puncta) increases from a very few
(approximately 0) to approximately 80 per cell in 3–7
DIV E18 hippocampal cultures [40]. The rate of increase
in the number of synapses is proportional to cell den-
sity in these cultures. Spontaneous Ca2+ currents were
observed in slices from the hippocampus at E17, and
the number of active cells increased approximately
8-fold in about 4 days [41]. Also, synchronous oscilla-
tion of Ca2+ transients was seen at 7 DIV but not at 3
DIV; synaptic activity further increased between 7 DIV
and 14 DIV in cultures of E18 rat cortical neurons.
Therefore, neurons in cultures from embryonic brains
form functional synapses in parallel with dendritic growth.
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Figure 1. MAP1A Becomes Enriched in Den-
drites in Parallel with Dendritic Growth in
Both the Brain and Neuronal Cultures
(A) Immunolocalization of MAP1A in relation
to MAP2, NF-L, and MBP in a 6-month-old
rat brain. The molecular layer (Ml), Purkinje
layer (Pl), granule layer (Gl), and white matter
(WM) of the cerebellar cortex are indicated.
(B) MAP1A/NFL double immunostaining in the
corpus callosum (CC) at the midline of a
6-month-old brain and MAP1A/MPB in the al-
veus (al) and adjacent external capsule (ec).
(C) MAP1A/calbindin and MAP1A/MAP2 im-
munostaining in developing postnatal 9-day-
old cerebellar cortex.
(D) MAP1A/calbindin staining in Purkinje cells
cultured for 2 and 3 weeks. MAP1A dendritic
staining is only seen at 3 weeks, whereas cal-
bindin staining is clear at 2 weeks. Arrow-
heads trace the calbindin-positive/MAP1A-
negative axon. MAP1A was detected only in
the initial segment of these axons (indicated
by an arrow).
(E) Immunoblots of homogenates from hip-
pocampal cells cultured for 1–15 days.
MAP1A increases the most between 4 and
10 days.
(F) Dendritic length in hippocampal neurons
cultured for 3–12 days. Length increases are
greatest between 4 and 10 days.
(G) Actin (phalloidin) and MAP1A colocalize
in distal regions of a dendritic growth cone
of a 6 DIV hippocampal neuron. MAP2 is lo-
cated more proximally. An asterisk indicates
the identical position in each panel. Figure
S5 shows a color version of these panels.
The scale bar represents 5 m. Error bars
represent the standard error of the mean.
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1822Figure 2. Membrane Depolarization Alters MAP1A Expression via Ca2+ Channels and MAPK Activity, and Increased MAP1A Expression Is
Required for Activity-Enhanced Dendritic Growth and Branching
(A) (Top) MAPK activity in cell extracts after 0–45 min KCl treatment of 3 DIV hippocampal neurons was assayed by incorporation of 32P into
MBP substrate and visualized by Phosphorimager; (middle and bottom) ERK1 and ERK2 protein levels were unchanged in immunoblots.
(B) MAPK activity after treatment with KCl was determined with an in vitro phosphorylation assay that [46] that was quantified by phosphorim-
aging; note that the peak of MAPK activity is at 30 min after treatment.
(C) Western blots showing that active MAPK (A-MAPK) levels in cultures stimulated for 15 or 30 min with 50 mM KCl increased in comparision
to levels in unstimulated (50 mM NaCl) cells.
(D) Western blots showing MAP1A protein levels at 3 DIV (0 hr) and at different time points (12 and 24 hr) after treatment with KCl or NaCl;
KCl treatment led to a substantial increase in MAP1A levels 12–24 hr later. The KCl-mediated increase in MAP1A was completely blocked by
cotreatment with nimodipine (a blocker of L-type Ca2+ channels) or with PD98059 (an inhibitor of MAPK activity).
(E) KCl treatment had no effect on MAP1B and MAP2 protein levels.
(F) (Insert) Western blot showing that MAP1A siRNA (lane 2) blocked KCl-induced increases in MAP1A (lane 1); siRNA was applied for 36 hr,
starting 12 hr prior to KCl (applied at 3 DIV), and samples were collected 24 hr after the addition of KCl. Statistical comparisons between
NaCl-treated and KCl-treated samples were performed by ANOVA followed by post-hoc comparisons using the Tuckey test. (***) p < 0.0001
(stars in graph). Graphs showing that dendritic length and branching increased after KCl treatment (KCl) compared to NaCl treatment (for
controls; ctr). MAP1A siRNA transfection (siRNA1) blocked KCl-induced changes (siRNA1+KCl). Axonal length also increased with activity,
but MAP1A siRNA treatment did not affect axonal growth.
(G) Western blot showing that siRNA transfection reduces MAP1A protein levels in older cultures; for this experiment 5 DIV cultures were
transfected with siRNA1 for 36 hr. Lane 1, 5 DIV; lane 2, scrambled siRNA, 6.5 DIV; lane 3, MAP1A siRNA1, 6.5 DIV.
(H) MAP2/MAP1A immunostaining in 6 DIV control (ctr) and MAP1A siRNA (siRNA)-treated hippocampal neurons. Arrows outline cells. The
scale bar represents 10 m.
All error bars represent the standard error of the mean.At the earliest stages of dendritic growth in hippo-
campal cultures, MAP1A immunofluorescence was low
and widespread, including the nascent axon and asso-
ciated growth cones (Figure S4A). Dendritic growth
cones also stained prominently where MAP1A localized
distally, and it was especially prominent in actin-rich
filopodial extensions, a locale well suited for regulated
contact-dependent dendritic remodeling (Figure 1G;
Figure S5). Given that MAP1A has both microtubule and
actin binding activities [11–13], it could be involved in
mediating interactions between these cytoskeletal ele-
ments; such interactions are important for growth-cone
guidance and neurite extension [42] as well as for syn-
aptic growth [12]. In contrast to distal accumulation of
MAP1A, MAP2 staining at this stage was stronger in
proximal regions of dendrites.
In high-density cortical cultures, MAP1A became re-
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rtricted to dendrites of pyramidal neurons after about 2
eeks (Figures S4B–S4C). In younger cultures, MAP1A
istributed throughout cells, including the axon, with
nrichment in distal neurite regions. This juvenile pat-
ern of MAP1A was retained in cells grown in isolation
or 2 weeks (Figure S4C, “LD”), correlating with shorter
nd less branched dendrites in low-density cultures, as
ompared to higher-density cultures where cells are in
ontact with one another. Furthermore, in low-density
ippocampal cultures as opposed to high-density cul-
ures, a delay of 4–6 days was observed in MAP1A ac-
umulation in dendrites. Taken together, these observa-
ions suggested that cell-cell contact might regulate
AP1A levels and subcellular distribution. These find-
ngs prompted us to examine whether MAP1A expres-
ion was responsive to neuronal activity and played a
ole in the branching of dendrites.
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1823Figure 3. MAP1A Is Required for Elongation
and Stabilization of Dendritic Branches
(A) Dendritic length at the start of treatment
with siRNA and after 1.5 days of treatment
with scrambled (ctr) and MAP1A siRNAs.
The initial stage of dendritic growth (4–5.5
DIV) when primary dendrites were forming
was not affected significantly by treatment,
but as dendrites matured and elongated (6–
7.5 DIV or 10–11.5 DIV), growth was blocked
by MAP1A siRNA treatment. This effect was
most pronounced on the formation of sec-
ondary and higher-order dendrites.
(B) Graphs show the number of dendritic
branches in control siRNA and MAP1A siRNA-
treated cultures. MAP1A expression is re-
quired for formation and retention of second-
ary and higher-order dendritic branches. Bars
marked with an asterisk show significant dif-
ferences from age-matched control, and bars
marked with a number sign show significant
differences from values at the time of RNAi ad-
dition (start). Statistical analysis employed ANOVA post-hoc comparisons performed via the Tuckey test; p < 0.0001. In the presence of MAP1A
siRNA, higher-order dendrites were significantly shorter and had fewer branches than processes in 36-hr-younger cultures.
All error bars represent the standard error of the mean.To examine whether neuronal activity regulated
MAP1A expression, 3 DIV hippocampal cultures were
treated with 50 mM KCl. KCl-induced increases in filo-
podial extensions had been shown to depend on acti-
vation of L-type Ca2+ channels and the MAPK pathway
(reviewed in Wong and Gosh [3]). In our cultures, a 30
min treatment induced a rapid (15–30 min) activation of
MAPK, with no significant changes in ERK1 and ERK2
protein levels (Figures 2A–2C). Pretreatment with ni-
modipine, an L-type calcium-channel blocker, inhibited
KCl activation of MAPK by 80% (not shown).
A 30–60 min KCl treatment resulted in a significant
increase in MAP1A protein levels (Figure 2D; Table S2)
After 12–24 hr, Nimodipine and PD98059, a MEK inhibi-
tor, were applied prior to KCl treatment and blocked
increases in MAP1A (Figure 2D). In contrast, no changes
in MAP1B and MAP2 were observed after the addition
of KCl (Figure 2E). In parallel with the KCl-induced in-
crease in MAP1A levels, total dendritic length increased
from 184 ± 28 m (untreated) to 396 ± 44 m (KCl), and
the number of dendritic branches increased from 10.7 ±
0.3 to 18.2 ±0.4 (Figure 2F). Effects on dendritic length
and number were blocked by pretreatment with nimodi-
pine or PD98059; under these circumstances, dendritic
lengths after KCl stimulation remained at 178 ± 12 m
and 180 ± 18 m, respectively (Table S2). Activity also
enhanced axonal growth (528 ± 36 m [untreated] to
680 ± 32 m [KCl] [Figure 2F]). In summary, neuronal
activity triggered by activation of L-type Ca2+ channels
induced MAP1A expression in 3 DIV neurons to levels
normally seen only after about a week. Therefore, we
next examined if MAP1A was necessary for activity-
induced neurite growth.
Activity modulation of dendritic remodeling was first
suggested by a correlation between the timing of affer-
ent growth/activity and dendritic maturation in the de-
veloping brain and was subsequently demonstrated di-
rectly in neuronal cultures [3]. KCl-induced increases in
filopodial extensions were previously shown to require
activation of L-type Ca2+ channels and the MAPK path-way [43, 44]. To evaluate whether MAP1A was required
for activity-induced increases in dendritic length and
arborization, we treated 3 DIV cultures with MAP1A
siRNA before KCl application. MAP1A expression was
reduced 36 hr after transfection with siRNA in 40%–
60% of cells (Figure 2F), with no effect on MAP2 or
MAP1B levels, (Table S3); actin and tubulin were also
unaffected by siRNA treatment. Finally, we confirmed
that MAP1A siRNA blocked KCl-induced increases in
MAP1A protein levels (Figure 2F; Table S3).
As expected, in young cultures, MAP1A siRNA treat-
ment on its own did not alter process growth because
MAP1A protein levels are relatively low at this stage of
development. Reducing MAP1A levels had no effect on
MAPK activity in 3 DIV cultures (see Table 1). Quantita-
tive Western blots with antibodies against total ERK1/
ERK2 in cells treated with scrambled or specific siRNA
for MAP1A show that ERK1/ERK2 protein levels are
comparable with and without MAP1A or KCl treatment
at 3 DIV. Similarly, the extent of MAPK activation by KCl
treatment was comparable with and without MAP1A, as
shown by immunoreactivity with an antibody against
active phospho-MAPK (Table 1).
The mean total length of dendrites was 184 ± 28 m
(untreated) versus 161 ± 43 m (MAP1A siRNA), and
the number of dendritic branches was 10.7 ± 0.3 (un-
treated) versus 8.2 ± 0.6 (MAP1A siRNA) in 4.5 DIV cul-
tures (Figure 2F). However, suppressing MAP1A expres-
sion completely blocked activity-induced increases in
dendritic length (KCl at 396 ± 44m versus KCl + siRNA
at 191 ± 33 m) and branching (KCl at 18.2 ± 0.4
branches versus KCl + siRNA at 9.4 ± 0.6 branches).
This effect on neurite growth was specific to dendrites;
MAP1A siRNA treatment did not affect KCl-induced en-
hancement of axon growth (Figure 2F). No differences
in axonal length, as revealed by labeling with TAU1
mAb, were detected between MAP1A suppressed neu-
rons and controls. In summary, increases in MAP1A
were required for activity-induced remodeling of the
dendritic arbor, with no effect on axon growth. The
Current Biology
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MAP1A expression in older cultures (Figures 2G and
2H), so we evaluated whether sustained MAP1A ex-
pression was required for the dendrite elongation and
arborization that are normally prompted by synaptic ac-
tivity in high-density cultures.
As noted above, MAP1A siRNA treatment of 3–4 DIV
cultures, in which there are no synapses and MAP1A
levels are low, had no effect on dendrite or axon length
measured 36 hr later (Figures 2F and 3A). In contrast,
MAP1A-supressed neurons displayed shorter and less
branched dendrites compared to controls in cultures
older than 7 DIV. The mean length of dendrites in cul-
tures treated with MAP1A siRNA at 6 DIV was 288 ± 46
m at 7.5 DIV, whereas it was 625 ± 57 m in control
cells. Similarly, total dendritic length was reduced in
11.5 DIV MAP1A siRNA-treated cultures (from 1326 ±
108 m to 881 ± 34) (Figure 3A). In control cultures,
there is robust growth at this time (Figure 1F; Table S1).
In light of the fact that MAP1A preferentially localized
to distal dendrites in developing neurons (Figure 1G;
Figure S5), effects on primary and higher-order den-
drites were evaluated separately for the 6–7.5 DIV treat-
ment. This analysis revealed that MAP1A suppression
preferentially affected the length of higher-order branches.
Interestingly, MAP1A siRNA did not block dendritic
growth stimulated by BDNF (data not shown), a factor
that preferentially induces primary dendrites and proxi-
mal branches [45].
A comparison of the number of branches before and
after MAP1A siRNA treatment revealed a requirement
for MAP1A in the stabilization of dendritic arbors (Fig-
ure 3B). Although the number of first-order dendrites
did not change with MAP1A siRNA, the number of
higher-order branches was significantly lower than in
age-matched controls; surprisingly, dendrites were even
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fTable 1. Suppression of MAP1A with siRNA Does Not Affect Basal
Levels of MAPK or Activation of MAPK by KCl
Groups ERK1 and ERK2 A-MAPK
Scrambled + NaCl 642 ± 24 116 ± 8
Scrambled + KCl 645 ± 15 894 ± 36***
SiRNA1+ NaCl 638 ± 28 122 ± 12
SiRNA1 + KCl 630 ± 15 945 ± 27***
Protein levels of Erk1/Erk2 were evaluated by quantitative im-
munoblot with specific antibodies against total Erk or active MAPK.
Densitometry of ERK1/ERK2 or A-MAPK (active MAPK) Western
blots were performed with Scion Image software. Quantification
was performed in triplicate samples and replicated at least three
times. Each value represents the mean ± SEM. Values are ex-
pressed in arbritrary units based on pixel intensity normalized to
band area after subtraction of backgrounds. Statistical compar-
isons between NaCl-treated and KCl-treated samples were
performed with ANOVA methods followed by post-hoc compar-
isons using the Tuckey test. Asterisks indicate p < 0.0001. The
A-MAPK immunoreactivity after KCl stimulation for both Scram-
bled- and siRNA1-treated cells was significantly different from that
in the corresponding unstimulated controls but was not signif-
icantly different in either non-control group. For this experiment, 2
DIV cultures were treated with scrambled or siRNA1 oligonucleo-
tides for 24 hours; immediately afterwards NaCl or KCl was added
to the culture medium for 60 min. The cells were then scraped, and
extracts were obtained and processed for SDS-PAGE and
Western blotting.
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tless branched than in younger cultures. Most strikingly,here were only 0.4 ± 0.1 higher-order branches in siRNA-
reated cultures at 7.5 DIV as opposed to 3.6 ± 0.2 at
he beginning of treatment at 6 DIV. These observations
how that MAP1A siRNA not only inhibited dendritic
rowth but also resulted in the retraction of dendritic
rocesses. In summary, these results indicate that inhi-
ition of MAP1A expression specifically reduces the
ize of the terminal dendritic arbor. Because MAP1A
iRNA blocked dendritic growth at the time when syn-
pses form, we tested whether spontaneous synaptic
ctivity regulated MAP1A expression. Therefore, 6 DIV
ultures were treated with tetrodotoxin (TTX, 1 M) for
4 or 36 hr, and then MAP1A levels and dendritic mor-
hology were analyzed. TTX significantly decreased
AP1A levels but not MAP2 or tubulin protein levels
Figures 4A–4B); it also reduced the number of second-
nd higher-order dendritic branches (Figure 4C), as well
s total dendritic length (Figures 4D and 4E).
Our results implicate MAP1A in activity-stimulated
ranching and stabilization of the terminal dendritic ar-
or without affecting axon growth and determination or
nitial outgrowth and elongation of primary dendrites.
lthough most studies on synaptic remodeling have fo-
used on channel activity and signal transduction,
here are precedents for a cytoskeletal-associated pro-
ein’s playing a role. For example, β-catenin is another
olecule that is a candidate for mediating effects of
euronal activity on dendritic branching by acting lo-
ally through the actin cytoskeleton, rather than via
ene activation [1]. The effects of MAP1A are more se-
ere than with β-catenin sequestration. Although spe-
ific mechanisms for MAP1A effects are not fully under-
tood, MAP1A has the potential to mediate interactions
etween actin and microtubule cytoskeletons [12, 13]
r to interact directly with postsynaptic components
uch as ion channels [19]. Suppression of MAP1A levels
ot only inhibited activity-induced dendritic branching but
lso induced retraction of existing branches. In addition,
uppression of MAP1A led to an attenuation of normal
ctivity-dependent dendritic growth and to the retrac-
ion of terminal branches. Taken together with observa-
ions that in vivo MAP1A levels increase at the time of
ynaptogenesis and that MAP1A associates with syn-
ptic proteins [19, 34, 35], we conclude that MAP1A
ay be a critical factor for activity-dependent dendritic
odeling in the maturing brain.
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1825Figure 4. Effects of TTX Treatment on MAP1A and Dendritic Morphology
(A) Western blots showing MAP1A, MAP2, and β-tubulin (Tub) protein levels in control and TTX-treated cultures; lane 1, 6 DIV cultures; lane
2, vehicle-treated 7.5 DIV cultures; lane 3, TTX-treated 7.5 DIV cultures.
(B) Graphs showing changes in MAP1A, MAP2, and β-tubulin protein levels after treatment with TTX; values are expressed as percent of
change with respect to the 6 DIV control group (100%).
(C) Graph showing changes in the number of dendritic branches between control and TTX-treated cultures. All measurements were performed
at 7.5 DIV, and cultures were treated with TTX for 36 hr.
(D and E) Immunofluorescence micrographs showing dendritic morphology in 7.5 DIV hippocampal neurons from control (D) and TTX-treated
(E) cultures. Cells were stained with a MAP2 mAb; numbers indicate branch order. The scale bar represents 10 m.
All error bars represent the standard error of the mean.Received: January 3, 2005
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